2 vegetable capsules per serving | 300 mg active Alpha-GPC | 30 servings | 60 capsules | Raw-material strength must be confirmed
Alpha GPC product pages often blur the amount and the weight of the supplied Alpha GPC ingredient. This Alpha GPC page should do the opposite. The current Alpha GPC product target is 300 milligrams of Alpha GPC per two capsule serving with 30 servings, in a 60 capsule bottle. If the selected Alpha GPC material is diluted on a carrier production requires than 300 milligrams of that Alpha GPC material.The exact input and any 50% statement stay on hold until the approved specification and COA identify the raw-material strength.
| Ingredient | Amount per serving |
| Active Alpha-GPC | 300 mg per serving |
| Serving size | 2 vegetable capsules |
| Pack | 60 capsules / 30 servings |
| Raw-material strength and input | Confirm by supplier specification and COA before publication |
I would say that the amount shown to customers is 300 milligrams of active AlphaGPC, for each serving. I recommend you keep the word active whenever it helps avoid confusion in a quotation or specification that also lists the weight of the purchased ingredient.
Do not call a product that has an ingredient and list 600 mg of active Alpha-GPC. On the hand do not think that 300 mg of a provided powder gives 300 mg active. Do not call a product that has an ingredient and list 600 mg of active Alpha-GPC. On the hand do not think that 300 mg of a provided powder gives 300 mg active.The label, batch formula and sales materials need one consistent basis.
If an approved raw material is confirmed at 50% Alpha-GPC, a 600 mg ingredient input would be required to deliver 300 mg active before manufacturing tolerances are considered. That is a calculation, not yet a confirmed fact for this product.
The page should keep the 600 mg and 50% wording out of public copy until the supplier specification and COA support both numbers. A different strength would change the input, capsule load, cost and possibly the serving design.
The serving uses two vegetable capsules. Once the raw-material strength and required input are known, a trial blend can confirm bulk density, flow, excipient need and capsule size. The active amount alone cannot predict whether the commercial fill will fit.
The current bottle has 60 capsules. Offers 30 servings. Any change, to the shell size the number of capsules taken each day or the quality of the materials must be shown in the directions the net quantity and the quotation.
The approved Alpha-GPC material should be reviewed for its stated storage and handling conditions. Packaging decisions should follow the supplier documents and finished-product stability plan rather than a generic nootropic pack specification.
Bottle barrier, closure, induction seal, desiccant decision and packaging exposure during filling all belong in the project review. Do not publish a shelf-life claim until the selected raw material, finished capsule and commercial pack have a supporting plan.
This page earns its own search intent by explaining an Alpha-GPC dose and raw-material specification. It should not repeat the multi-ingredient stories used for phosphatidylserine, ginkgo, DHA or lutein products.
Keep public claims conservative.The product is not a treatment for dementia. It is not a treatment for ADHD. It is not a treatment, for a memory disorder. The page should not promise memory. The page should not promise focus. The page should not promise cognitive performance.
Any permitted support statement needs evidence for the actual material and serving.
That is the current product target. The final label and batch formula must both express the active basis consistently.
Only after the approved supplier specification and COA confirm a 50% grade and the master formula confirms the input.
The serving allows room for the required ingredient and excipients, but the final shell and fill still need a physical trial after the raw-material strength is known.
Send the target market, required active Alpha-GPC amount, available supplier specification, capsule and pack preference, and expected quantity. HEKONA will review the input calculation, fill trial, label basis, MOQ and quotation.
This formula is intended for adults who prefer a focused Alpha-GPC supplement with a clearly stated active amount.
It may suit product lines targeting:
Final target-user wording, directions and claims should be reviewed for the intended sales market before label approval.
Whether you’re exploring new solutions, seeking technical support, or ready to start a project,our team is here to listen and collaborate.
